tiprankstipranks
Advertisement
Advertisement

ATRC Stock Latest News

AtriCure Shareholders Approve Expanded Equity and Governance Plans
Company AnnouncementsAtriCure Shareholders Approve Expanded Equity and Governance Plans
13d ago
8K
ATRC
Atricure Faces Ongoing and Potential New Risks Despite No Changes to 2025 10‑K Disclosures
PremiumCompany Announcements
Atricure Faces Ongoing and Potential New Risks Despite No Changes to 2025 10‑K Disclosures
25d ago
ATRC
AtriCure price target raised to $55 from $53 at Canaccord
PremiumThe Fly
AtriCure price target raised to $55 from $53 at Canaccord
25d ago
ATRC
AtriCure participates in a conference call with JPMorgan
PremiumThe Fly
AtriCure participates in a conference call with JPMorgan
25d ago
ATRC
AtriCure Earnings Call Highlights Profitable Growth Pivot
PremiumCompany Announcements
AtriCure Earnings Call Highlights Profitable Growth Pivot
26d ago
ATRC
AtriCure reports Q1 EPS ,0c consensus (6c)
PremiumThe FlyAtriCure reports Q1 EPS ,0c consensus (6c)
27d ago
ATRC
Is ATRC a Buy, Before Earnings?
Premium
Pre-Earnings
Is ATRC a Buy, Before Earnings?
29d ago
ATRC
AtriCure initiated with a Buy at Freedom Capital
Premium
The Fly
AtriCure initiated with a Buy at Freedom Capital
2M ago
ATRC
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
PremiumMarket News
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
3M ago
DEC
ATRC
AtriCure Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
AtriCure Earnings Call Highlights Growth Amid Headwinds
3M ago
ATRC
AtriCure: Underappreciated Moat, Growing Profitability, and Long-Term Upside in Underpenetrated Cardiac Markets
PremiumRatings
AtriCure: Underappreciated Moat, Growing Profitability, and Long-Term Upside in Underpenetrated Cardiac Markets
3M ago
ATRC
AtriCure price target lowered to $55 from $60 at UBS
PremiumThe Fly
AtriCure price target lowered to $55 from $60 at UBS
3M ago
ATRC
AtriCure price target lowered to $53 from $64 at Canaccord
PremiumThe FlyAtriCure price target lowered to $53 from $64 at Canaccord
3M ago
MDT
ATRC
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
Premium
Ratings
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
3M ago
ATRC
Oppenheimer downgrades AtriCure on new competition from Edwards
Premium
The Fly
Oppenheimer downgrades AtriCure on new competition from Edwards
3M ago
EW
ATRC
AtriCure downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
AtriCure downgraded to Perform from Outperform at Oppenheimer
3M ago
ATRC
AtriCure price target lowered to $52 from $60 at Citizens
PremiumThe Fly
AtriCure price target lowered to $52 from $60 at Citizens
3M ago
ATRC
Closing Bell Movers: Palo Alto Networks down 8% on soft guidance
PremiumThe Fly
Closing Bell Movers: Palo Alto Networks down 8% on soft guidance
3M ago
CE
ADI
AtriCure sees FY26 adjusted EPS 0c-4c, consensus (1c)
PremiumThe Fly
AtriCure sees FY26 adjusted EPS 0c-4c, consensus (1c)
3M ago
ATRC
AtriCure reports Q4 adjusted EPS 6c, consensus (11c)
PremiumThe FlyAtriCure reports Q4 adjusted EPS 6c, consensus (11c)
3M ago
ATRC
ATRC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ATRC Earnings this Week: How Will it Perform?
4M ago
ATRC
AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
Premium
Ratings
AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
4M ago
ATRC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >